Welcome to our dedicated page for ICON PLC SEC filings (Ticker: ICLR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to U.S. Securities and Exchange Commission filings for ICON plc (NASDAQ: ICLR), a Dublin, Ireland‑based clinical research organisation operating in the research and development in biotechnology industry. As a foreign private issuer, ICON files an annual report on Form 20‑F and furnishes current information on Form 6‑K.
ICON’s Form 6‑K submissions include press releases and other information made public in its home market or to shareholders. Recent 6‑K filings incorporate quarterly financial results, unaudited interim financial statements, updates on financial guidance, details of vaccine study developments, conference call schedules, participation in investor and healthcare conferences, and announcements such as CEO transitions and annual general meeting outcomes.
The company’s financial statements and related disclosures, referenced in its filings, present information on revenue, costs and expenses, income from operations, net income, cash flows and balance sheet items. They also describe elements of ICON’s capital structure, including bank credit lines, loan facilities and senior secured notes, as well as goodwill and intangible assets such as customer relationships, trade names, technology‑based assets and order or production backlog.
Through this filings page, users can review ICON’s regulatory history, including how it reports non‑GAAP measures like adjusted EBITDA, adjusted net income and adjusted diluted earnings per share, and the items excluded from those metrics. Filings are sourced in real time from the SEC’s EDGAR system, and AI‑powered tools on Stock Titan can help summarise lengthy documents, highlight key sections and make complex accounting and disclosure topics easier to understand for investors and researchers following ICON plc.
Artisan Partners filed Amendment No. 1 to a Schedule 13G reporting a beneficial ownership position in ICON plc Ordinary Shares (CUSIP G4705A100). The filing discloses ownership of 7,184,870 shares, equal to 9.0% of the class based on 79,483,795 shares outstanding as of 06/05/2025. The reporting group reports no sole voting or dispositive power, shared voting power of 6,946,790 and shared dispositive power of 7,184,870.
The statement notes that 5,518,132 of the shares are held on behalf of Artisan Funds and that the shares were acquired on behalf of discretionary clients of Artisan Partners Limited Partnership. The filing certifies the holdings are in the ordinary course of business and not intended to change control and is signed by Gregory K. Ramirez. A joint filing agreement is included as an exhibit.
Icon Plc (ICLR) submitted a Form 144 notice reporting a proposed sale of 381 common shares through Morgan Stanley Smith Barney LLC on NASDAQ, with an aggregate market value of $59,992.98. The form lists 77,772,130 shares outstanding and shows the shares were acquired on 08/07/2025 by restricted stock vesting under a registered plan and are to be sold on or about 08/08/2025. The filing reports Nothing to Report for securities sold in the past three months.
The notice includes the filer’s representation that they are unaware of undisclosed material adverse information. Several issuer/filer identification fields in the form are left blank in the provided content.
Icon Plc filed a Rule 144 notice proposing the sale of 1,136 common shares with an aggregate market value of $178,876.72. The sale is to be executed through Morgan Stanley Smith Barney LLC on NASDAQ with an approximate sale date of 08/08/2025. The filing reports 77,772,130 shares outstanding, giving context to the size of this proposed transaction.
The securities were acquired on 08/07/2025 as restricted stock vesting under a registered plan from the issuer and the stated nature of payment is services rendered. The filer reports nothing to report for securities sold during the past three months and includes the standard representation that the signer knows of no undisclosed material adverse information about the issuer.
ICON (Nasdaq:ICLR) filed a routine Form 6-K that simply furnishes Exhibit 99.1 titled “ICON plc Schedules Second Quarter 2025 Earnings Conference Call.” The notice contains no financial statements, guidance, or operational updates. It also confirms the company continues to file annual reports on Form 20-F. The document was signed by Chief Financial Officer Nigel Clerkin on 23 June 2025.
ICON plc (Nasdaq: ICLR) has submitted a routine Form 6-K dated 18 June 2025 to the U.S. Securities and Exchange Commission. The filing confirms that the company continues to report under Form 20-F requirements for foreign private issuers and is signed by Chief Financial Officer Nigel Clerkin.
The sole attachment, listed as Exhibit 99.1, contains the company’s Unaudited Interim IFRS Single Company Financial Statements. No numerical results, earnings data, or transaction details are provided in the cover document itself. As such, the submission appears to be an administrative update intended to place the interim financial statements on the public record.
FAQ
What is the current stock price of ICON PLC (ICLR)?
What is the market cap of ICON PLC (ICLR)?
